Interleukin 17-producing T helper cells in alloimmunity (Q37332692)

19 August 2017

1 reference

title

Interleukin 17-producing T helper cells in alloimmunity (English)

1 reference

19 August 2017

0 references

Fleur Samantha Benghiat

1

1 reference

19 August 2017

Louis Marie Charbonnier

2

1 reference

19 August 2017

Benoit Vokaer

3

1 reference

19 August 2017

Virginie De Wilde

4

1 reference

19 August 2017

Alain Le Moine

5

1 reference

19 August 2017

publication date

1 January 2009

1 reference

19 August 2017

published in

Transplantation Reviews

1 reference

19 August 2017

volume

23

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

11-18

1 reference

The complementary roles of deletion and regulation in transplantation tolerance

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

A role for eosinophils in transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Multiple pathways to allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Cytokines and the Th1/Th2 paradigm in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

How microorganisms tip the balance between interleukin-12 family members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+Regulatory T Cells by Induction of IDO in Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interferon Gamma: Friend or Foe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Understanding FOXP3: progress towards achieving transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Foxp3-dependent programme of regulatory T-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

TLR engagement prevents transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Critical Influence of Natural Regulatory CD25+ T Cells on the Fate of Allografts in the Absence of Immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Dominant transplantation tolerance. Opinion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Allograft rejection mediated by memory T cells is resistant to regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Phenotypic and functional features of human Th17 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-17 family members and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Cellular mechanisms underlying acute graft rejection: time for reassessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

The interleukin-12 family: new players in transplantation immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Toll-like receptors and allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Regulation of T helper 17 differentiation by orphan nuclear receptors: it's not just ROR gamma t anymore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Th17: an effector CD4 T cell lineage with regulatory T cell ties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-12 family members and the balance between rejection and tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Development, cytokine profile and function of human interleukin 17-producing helper T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Increased expression of interleukin 17 in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-17 antagonism inhibits acute but not chronic vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Expression of interleukin-17 as a predictive parameter in acute renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

The role of interleukin-17 during acute rejection after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Anti-Type V Collagen Lymphocytes that Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

Interleukin-6: a new therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2008.08.007

10.1016/J.TRRE.2008.08.007

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference